Life sciences software & AI news

Showing 1000+ results

Sep 3, 2026

EClinCloud Surpasses 1,100 Clinical Trials Across 10+ Countries as Its Unified AI-Driven Platform Expands Worldwide

China-built clinical research platform now serves 300+ pharmaceutical, biotech and CRO organizations and 20,000+ users, uniting EDC, RTSM, eCOA, independent review, CTMS and eTMF with embedded AI agents on a single data model.NINGBO, China, Sept. 3, 2026 /PRNewswire/ -- EClinCloud (Ningbo) Technology Co., Ltd., developer of a unified, AI-driven clinical research platform, today announced that its technology now supports more than 1,100 clinical trials for 300+ sponsor and research organizations

A minimalist illustration of a light bulb and circuit board in a dark palette.

Sep 3, 2026

NVIDIA Acquires Hugging Face for $12.93 Billion

NVIDIA has officially announced its acquisition of Hugging Face for $12.93 billion, aiming to enhance the platform's infrastructure and broaden access to AI technologies globally.The partnership is set to benefit a vast community of over 18 million developers, researchers, and creators who utilize Hugging Face, which hosts more than 3 million models, 500,000 datasets, and 1 million applications. With more than 200,000 companies leveraging the platform for AI deployment, NVIDIA stands as a signif

Sep 3, 2026

Press release

Authenticx Expands Pharmacovigilance AI to Automate Downstream Safety Workflows With Accuracy

New capabilities build on Authenticx's established adverse event detection technology, connecting patient conversations with pharmaceutical manufacturers' existing safety workflowsINDIANAPOLIS, Sept. 3, 2026 /PRNewswire/ -- Authenticx, whose AI turns millions of healthcare conversations into system-critical intelligence for pharmaceutical, payer and provider organizations, announced expanded capabilities for its Pharmacovigilance (PV) AI Solution. Building on its 2024 safety-event detection, the

Augmented reality headset in a rehabilitation room

Sep 3, 2026

UK MedTech Strolll secures €5 million in Innovate UK funding and additional IW Capital-led investment

Strolll, a UK-based MedTech company specializing in augmented reality applications for neurorehabilitation, has successfully raised €5 million in funding, including a significant loan from Innovate UK and investment from IW Capital.The funding consists of a €4.18 million innovation loan from Innovate UK and an additional €813.2k Growth Catalyst Investor Partnerships award, aimed at supporting two separate projects within the company. This financial boost follows a previous €12.2 million Series A

Sep 3, 2026

Press release

PharmPix President and CEO Dr. Martty Martínez Fraticelli Wins PBMI Excellence Award for Clinical Innovation

Recognition honors Martínez Fraticelli's vision for bringing clinical intelligence into pharmacy benefit decisions before risk and cost escalateGUAYNABO, Puerto Rico, Sept. 3, 2026 /PRNewswire/ -- PharmPix today announced that President and CEO Dr. Martty Martínez Fraticelli, Pharm.D., has received a 2026 PBMI Excellence Award for Clinical Innovation from the Pharmacy Benefit Management Institute (PBMI).The recognition honors Martínez Fraticelli's leadership in advancing a more clinically driven

Sep 3, 2026

Press release

Accelerate Regulatory Writing with Gen-AI Without Prompt Engineering, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn how generative AI can support regulatory writing without requiring complex prompt engineering. The featured speaker will discuss content-based mapping, document reuse and working directly within Microsoft Word to streamline regulatory document development. Attendees will also explore how this approach can improve consistency and efficiency while keeping medical writers in control of scientific judgment and content review.TORONTO, Sept. 3, 2026 /PRNewswire/ -- Generati

Sep 3, 2026

Press release

Abcam and Genedata Collaborate to Accelerate AI-Driven Antibody Development at Global Scale

The partnership combines Abcam's expertise in antibody development with Genedata's proprietary data model and enterprise platform to enhance data connectivity, accelerate innovation, and help deliver high-quality reagents to researchers faster.BASEL, Switzerland, Sept. 3, 2026 /PRNewswire/ -- Genedata, the leading provider of enterprise software for biopharmaceutical R&D, today announced an expanded collaboration with Abcam, a global provider of validated antibodies and assay solutions. By d

Sep 3, 2026

Press release

Syra Health, in Partnership with HealthSync, Selected for CMS ACCESS Model, Advancing Long-Term Growth Strategy

CARMEL, Ind., Sept. 3, 2026 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA) ("Syra Health" or the "Company"), an integrated healthcare solutions company powering better health outcomes through prevention-focused, accessible, and affordable solutions, announced today that, in partnership with HealthSync, it has been accepted into the CMS (Centers for Medicare & Medicaid) ACCESS (Advancing Chronic Care with Effective, Scalable Solutions) model. Inclusion in the federal program reinforces the C

A screening invitation letter on a doctor's desk

Sep 3, 2026

Netcompany claims NHS contract to help digitise screening

Netcompany has secured a substantial five-year contract with NHS England, valued at over £215 million, to enhance the digital framework for adult screening programs across the UK.This contract encompasses all seven national adult screening initiatives, including those for breast, cervical, and bowel cancers, which collectively generate approximately 15 million invitations annually and are critical for saving lives. The digital infrastructure will be integral to the NHS Digital Prevention Service

Sep 3, 2026

Press release

Gravie Launches Industry's First Hybrid Benefit Solution as an Answer to Employers Facing Rising Healthcare Costs

Edge™ is a first-of-its-kind plan design that allows employers to use level-funded and employer-funded individual-market coverage options within one coordinated benefits program.MINNEAPOLIS, Sept. 3, 2026 /PRNewswire/ -- Gravie, the health benefits company reinventing coverage for small and midsize employers, today announced the launch of Edge, a first-of-its-kind health benefits solution that allows employers to offer both an Individual Coverage Health Reimbursement Arrangement (ICHRA) and leve

A minimalist illustration of a DNA strand and molecule representing AI in drug discovery.

Sep 3, 2026

Boehringer signs AI drug discovery deal with Owkin

Boehringer Ingelheim has partnered with Owkin to enhance its drug discovery efforts through the AI platform K Pro, joining other pharmaceutical giants like Sanofi and AstraZeneca in leveraging this innovative technology.K Pro, introduced at the previous ESMO cancer congress, functions as an AI Scientist, enabling researchers to analyze complex medical data using straightforward language rather than intricate coding. This platform assists in uncovering biological patterns, disease characteristics

Sep 3, 2026

Press release

ACTO obtient le statut de partenaire produit gold de Veeva, à l'issue d'une collaboration de près d'une décennie au service de la réussite commune de leurs clients

Les intégrations validées avec les applications Veeva permettent aux équipes de terrain du secteur des sciences de la vie de se former, de s'entraîner et d'agir en s'appuyant sur des contenus approuvés et des informations en temps réel.TORONTO et NEW YORK, 3 septembre 2026 /PRNewswire/ -- ACTO, qui allie l'intelligence humaine à une IA empathique dans le domaine des sciences de la vie, a annoncé aujourd'hui avoir obtenu le statut de partenaire produit gold de Veeva, sur la base d'une collaborati

Back to start
Previous
Page 32 of 84
Next

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Platform

Legal